These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6637470)

  • 21. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
    Pattaragarn A; Alon US
    Pediatr Nephrol; 2003 Oct; 18(10):1073-6. PubMed ID: 12883974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of polyuria in nephrogenic diabetes insipidus due to aquaporin-2 deficiency.
    Hochberg Z; Even L; Danon A
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):39-44. PubMed ID: 9797845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin-aldosterone axis in patients with diabetes insipidus.
    Antaraki A; Rangou D; Chlouverakis C
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):505-10. PubMed ID: 8187317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy.
    Vokes TJ; Gaskill MB; Robertson GL
    Ann Intern Med; 1988 Feb; 108(2):190-5. PubMed ID: 3341651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination of thiazide diuretics and prostaglandins inhibitors in the treatment of nephrogenic diabetes insipidus].
    Pichetti D; Pandolfi ML; Bartuli A; Manca Bitti ML
    Clin Ter; 1985 May; 113(4):281-7. PubMed ID: 4017506
    [No Abstract]   [Full Text] [Related]  

  • 26. Indomethacin treatment for polyhydramnios and subsequent infantile nephrogenic diabetes insipidus.
    Smith LG; Kirshon B; Cotton DB
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):98-9. PubMed ID: 2197875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.
    Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M
    Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of 1-beta-oxyethyl-2-phenyl-methyl-piperidine in 6 cases of diabetes insipidus in children].
    Mouzet MT; Balsan S; Royer P
    Arch Fr Pediatr; 1968 Feb; 25(2):189-201. PubMed ID: 5245334
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors.
    Libber S; Harrison H; Spector D
    J Pediatr; 1986 Feb; 108(2):305-11. PubMed ID: 3080575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin and saluretics in nephrogenic diabetes insipidus of early infancy].
    Reimold EW
    Z Kinderheilkd; 1967; 101(1):6-19. PubMed ID: 4301709
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the renin-angiotensin system in diabetes insipidus and psychogenic polydipsia.
    Saruta T; Fujimaki M; Ogihara T; Saito I; Konishi K; Kondo K
    Nephron; 1982; 32(1):14-7. PubMed ID: 6757776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occult diabetes insipidus of a pitressin-resistant and familial type in infants. Presentation of a case].
    Gandullia E; Lignana E
    Minerva Pediatr; 1979 Mar; 31(6):429-34. PubMed ID: 470886
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe lithium-induced diabetes insipidus in a surgical patient treated with hydrochlorothiazide.
    Constandis DD; Schriever HG
    Am J Surg; 1981 Jun; 141(6):741-3. PubMed ID: 7246868
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium-induced nephrogenic diabetes insipidus treated with indomethacin.
    Martinez EJ; Sinnott JT; Rodriguez-Paz G; Oehler RL
    South Med J; 1993 Aug; 86(8):971-3. PubMed ID: 8351566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
    Knoers N; Monnens LA
    Pediatr Nephrol; 1992 Sep; 6(5):476-82. PubMed ID: 1457333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
    Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrogenic diabetes insipidus with fluorosis.
    Greenberg LW; Nelsen CE; Kramer N
    Pediatrics; 1974 Sep; 54(3):320-2. PubMed ID: 4414789
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus.
    Monn E
    Acta Paediatr Scand; 1981 Jan; 70(1):39-42. PubMed ID: 6782828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nephrogenic diabetes insipidus in five siblings].
    Hochberg Z
    Harefuah; 1977 Feb; 92(3):118-20. PubMed ID: 844747
    [No Abstract]   [Full Text] [Related]  

  • 40. Nephrogenic diabetes insipidus presenting with infantile hypotonia. A report of 2 cases.
    Sprenger KJ; Winship WS; Wittenberg DF
    S Afr Med J; 1986 Aug; 70(4):228-31. PubMed ID: 3738662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.